Use GHK-Cu serum first to support skin regeneration
Despite Dihexas structural derivation from Ang IV, mechanistic studies have established that the compound does not act through the classical AT 4 receptor (insulin-regulated aminopeptidase, IRAP)
These actions are likely due to the potential of BPC-157 to simulate vasodilatation and angiogenesis (new blood vessel formation) due to its action on peptidergic growth factors such as endothelial growth factor, Consequently, the peptide has demonstrated significant protective effects against gastric mucosal injury in rat models
Final Thoughts on GHK-Cu Research GHK-Cu continues to be widely discussed within peptide research communities as scientists explore peptide signaling and peptide interactions within laboratory environments
Those with cancer or active tumors should consult a physician before using growth-promoting peptides
Reviewed for documentation, presentation, labeling accuracy, internal QA, and direct in-house fulfillment handling